CELU CELULARITY INC Company Mergers 8-K Filing 2024 - Asset Acquisition Celularity Inc. acquired Sequence LifeScience's placental-derived allograft matrix product for $5.5 million, including an upfront payment of $1 million and potential milestone payments based on sales.Get access to all SEC 8-K filings of the CELULARITY INC